By Hannah Flynn | Medical News Today There is still research to be done into the best type of biomarkers to detect Alzheimer’s disease in different types of body fluid, said Dr. Thomas K Karikari, assistant professor of psychiatry at the University of Pittsburgh, who...
By Tom Avril | The Philadelphia Inquirer The FDA may approve a new drug for Alzheimer’s as soon as this week. But policy experts warn that the health care system is ill-equipped to identify which patients might be eligible for the drug, called lecanemab, as the...
By Carmen Leitch, Short-epitope Mapping | LabRoots Right now, there are no blood tests that can reliably diagnose Alzheimer’s disease on their own. Most people only get diagnosed with the neurodegenerative disorder after symptoms like memory loss arise, or...
Anastasia Gorelova-Pittsburgh | Futurity A new test detects a novel marker of Alzheimer’s disease neurodegeneration in a blood sample, researchers report. The biomarker, called “brain-derived tau,” or BD-tau, outperforms current blood diagnostic tests used to detect...
